Literature DB >> 10774476

Genetic disorders affecting proteins of iron metabolism: clinical implications.

S Sheth1, G M Brittenham.   

Abstract

Remarkable progress is being made in understanding the molecular basis of disorders of human iron metabolism. Recent work has uncovered unanticipated relationships with the immune and nervous systems, intricate interconnections with copper metabolism, and striking homologies between yeast and human genes involved in the transport of transition metals. This review examines the clinical consequences of new insights into the pathophysiology of genetic abnormalities affecting iron metabolism. The proteins recently found to be involved in the absorption, transport, utilization, and storage of iron are briefly described, and the clinical manifestations of genetic disorders that affect these proteins are discussed. This chapter considers the most common inherited disorder in individuals of European ancestry (hereditary hemochromatosis), a widespread disease in sub-Saharan populations for which the genetic basis is still uncertain (African dietary iron overload), and several less frequent or rare disorders (juvenile hemochromatosis, atransferrinemia, aceruloplasminemia, hyperferritinemia with autosomal dominant congenital cataract, Friedreich's ataxia, and X-linked sideroblastic anemia with ataxia).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10774476     DOI: 10.1146/annurev.med.51.1.443

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  8 in total

1.  Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals.

Authors:  Anthony S Grillo; Anna M SantaMaria; Martin D Kafina; Alexander G Cioffi; Nicholas C Huston; Murui Han; Young Ah Seo; Yvette Y Yien; Christopher Nardone; Archita V Menon; James Fan; Dillon C Svoboda; Jacob B Anderson; John D Hong; Bruno G Nicolau; Kiran Subedi; Andrew A Gewirth; Marianne Wessling-Resnick; Jonghan Kim; Barry H Paw; Martin D Burke
Journal:  Science       Date:  2017-05-12       Impact factor: 47.728

2.  Iron in neurodegenerative disorders.

Authors:  D. Berg; G. Becker; P. Riederer; O. Riess
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

3.  A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages.

Authors:  Stella Ekaputri; Eun-Kyung Choi; Manuela Sabelli; Luisa Aring; Kelsie J Green; JuOae Chang; Kai Bao; Hak Soo Choi; Shigeki Iwase; Jonghan Kim; Elena Corradini; Antonello Pietrangelo; Martin D Burke; Young Ah Seo
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-22       Impact factor: 12.779

Review 4.  SQUID biosusceptometry in the measurement of hepatic iron.

Authors:  Sujit Sheth
Journal:  Pediatr Radiol       Date:  2003-03-21

5.  Is the iron donor lipocalin 2 implicated in the pathophysiology of hereditary hemochromatosis?

Authors:  Hua Huang; Shizuo Akira; Manuela M Santos
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

6.  Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice.

Authors:  Darren N Seril; Jie Liao; Kwok-Lam K Ho; Asim Warsi; Chung S Yang; Guang-Yu Yang
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

Review 7.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

Review 8.  Iron-regulatory proteins: molecular biology and pathophysiological implications.

Authors:  Gaetano Cairo; Stefania Recalcati
Journal:  Expert Rev Mol Med       Date:  2007-12-05       Impact factor: 5.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.